Jennifer K Frediani
Overview
Explore the profile of Jennifer K Frediani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Carlson N, Frediani J, Corwin E, Dunlop A, Jones D
Biol Res Nurs
. 2020 Jan;
22(2):157-168.
PMID: 31983215
Objectives: The purpose of this study was to evaluate differences in the metabolic pathways activated in late-pregnancy serum samples among African American women who went on to have term (≥37...
32.
Collins J, Walker D, Jones D, Tukvadze N, Liu K, Tran V, et al.
PLoS One
. 2018 Oct;
13(10):e0205398.
PMID: 30308073
Introduction: Pulmonary tuberculosis (TB) is a major worldwide health problem that lacks robust blood-based biomarkers for detection of active disease. High-resolution metabolomics (HRM) is an innovative method to discover low-abundance...
33.
Vos M, Jin R, Konomi J, Cleeton R, Cruz J, Karpen S, et al.
Pilot Feasibility Stud
. 2018 Jul;
4:109.
PMID: 29992039
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in children, and currently, there are no FDA-approved therapies. Plasminogen activator inhibitor-1 (PAI-1) is elevated in children with...
34.
Arsik I, Frediani J, Frezza D, Chen W, Ayer T, Keskinocak P, et al.
Children (Basel)
. 2018 May;
5(6).
PMID: 29799476
Background: Validated noninvasive biomarkers to assess treatment response in pediatric nonalcoholic fatty liver disease (NAFLD) are lacking. We aimed to validate alanine aminotransferase (ALT), a monitoring biomarker for change in...
35.
Frediani J, Naioti E, Vos M, Figueroa J, Marsit C, Welsh J
Environ Health
. 2018 Jan;
17(1):6.
PMID: 29334960
Background: While associated with obesity, the cause of the rapid rise in prevalence of nonalcoholic fatty liver disease (NAFLD) in children, which is highest among Hispanics, is not well understood....
36.
Cioffi C, Welsh J, Cleeton R, Caltharp S, Romero R, Wulkan M, et al.
Children (Basel)
. 2017 May;
4(5).
PMID: 28467377
Little is known regarding the subsequent course of non-alcoholic fatty liver disease (NAFLD) diagnosed in childhood. The objectives of this single-center study were to gather data on long-term health outcomes...
37.
Alvarez J, Chong E, Walker D, Chandler J, Michalski E, Grossmann R, et al.
Metabolism
. 2017 May;
74:41-42.
PMID: 28456337
No abstract available.
38.
Alvarez J, Chong E, Walker D, Chandler J, Michalski E, Grossmann R, et al.
Metabolism
. 2017 Apr;
70:31-41.
PMID: 28403943
Background: Cystic fibrosis (CF) is a chronic catabolic disease often requiring hospitalization for acute episodes of worsening pulmonary exacerbations. Limited data suggest that vitamin D may have beneficial clinical effects,...
39.
Shaikh N, Frediani J, Ramakrishnan U, Patil S, Yount K, Martorell R, et al.
Public Health Nutr
. 2017 Jan;
20(7):1162-1172.
PMID: 28069093
Objective: To develop and evaluate a Nutrition Transition-FFQ (NT-FFQ) to measure nutrition transition among adolescents in South India. Design: We developed an interviewer-administered NT-FFQ comprising a 125-item semi-quantitative FFQ and...
40.
Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley K, Shenvi N, et al.
Am J Clin Nutr
. 2015 Sep;
102(5):1059-69.
PMID: 26399865
Background: Tuberculosis, including multidrug-resistant tuberculosis (MDR-TB), is a major global health problem. Individuals with tuberculosis disease commonly exhibit vitamin D deficiency, which may adversely affect immunity and the response to...